News
Start With A Large Snowball And Roll It Slowly But Surely
Since the Fed started to increase the interest rates in 2022, the yield chasing investors have finally accessed a better…
As Global Economies Diverge, Where Are The Investment Opportunities?
Last week, we published our midyear investment outlook, with an overarching theme of finding opportunities amidst divergence. We have Western…
Acadia Pharmaceuticals: Back In The Buy Zone (NASDAQ:ACAD)
Shares of central nervous system therapy concern Acadia Pharmaceuticals, Inc. (NASDAQ:ACAD) have recently fallen to their lowest level since its…
Visa: One Of The Best Dividend Growth Stocks Of All Time Is On Sale (NYSE:V)
Now is not the time to fall prey to FOMO (the fear of missing out) and buy into the AI…
PDBC ETF: Commodities Bore Me (Technical Analysis) (NASDAQ:PDBC)
I don't mean to be flippant. I have invested in commodities through ETFs and stocks for a few decades. But…
Blue Owl Capital: Misunderstood Pessimism With A Highly Attractive Yield (NYSE:OBDC)
Blue Owl BDC Benefits From A Higher-For-Longer Fed Blue Owl Capital Corporation (NYSE:OBDC) investors suffered downward volatility over the past…
A Post-OPEX Liquidity Drain Could Rattle The Stock Market This Week
A window has opened between now and the end of June that could see the equity market start a sizeable…
Cogent Biosciences: Inflection Year Directly Ahead (NASDAQ:COGT)
Today, we are putting Cogent Biosciences (NASDAQ:COGT) in the spotlight for the first time since our look at this clinical…